| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/24/2001 | EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response |
| 10/24/2001 | EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting |
| 10/24/2001 | EP1146885A1 Pre-conditioning against cell death |
| 10/24/2001 | EP1146881A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 10/24/2001 | EP1146875A1 Myt1 kinase inhibitors |
| 10/24/2001 | EP1146874A1 Vitronectin receptor antagonist |
| 10/24/2001 | EP1146873A1 Anti-androgens and methods for treating disease |
| 10/24/2001 | EP1146869A2 Inhibition of stat3 signal transduction for human cancer therapy |
| 10/24/2001 | EP1146868A1 Anti-inflammatory agents |
| 10/24/2001 | EP1146863A1 Lyophilisates with improved reconstitutibility |
| 10/24/2001 | EP1146850A1 Use of a plant extract of the genus rosmarinus in compositions for treating ageing skin symptoms |
| 10/24/2001 | EP1146845A2 Compressed lecithin preparations |
| 10/24/2001 | EP1146790A1 Compounds and methods |
| 10/24/2001 | EP1146788A1 Amide derivatives for antiangiogenic and/or antitumorigenic use |
| 10/24/2001 | EP1146787A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 10/24/2001 | EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 10/24/2001 | EP0892796B1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| 10/24/2001 | EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 10/24/2001 | EP0858341B1 Combination therapy for advanced cancer comprising temozolomide and cisplatin |
| 10/24/2001 | EP0854721B1 Endothelin receptor antagonists |
| 10/24/2001 | EP0848704B1 Form iii crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 10/24/2001 | EP0840733B1 A triazolylmethyl-indole ethylamine bisulfate salt |
| 10/24/2001 | EP0840601B1 Thip for treating sleep disorders |
| 10/24/2001 | EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them |
| 10/24/2001 | EP0820433B1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 10/24/2001 | EP0775142B1 Substituted o6 -benzylguanines |
| 10/24/2001 | EP0711163B1 Use of benzydamine in the treatment of pathological conditions caused by tnf |
| 10/24/2001 | EP0660713B1 Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy |
| 10/24/2001 | EP0618802B1 Synthetic compounds and compositions with enhanced cell binding |
| 10/24/2001 | CN1319139A Polynucleotide constructs and uses thereof |
| 10/24/2001 | CN1319131A Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC |
| 10/24/2001 | CN1319100A Isoquinoline derivatives with angiogenesis inhibiting activity |
| 10/24/2001 | CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines |
| 10/24/2001 | CN1319096A Quinazoline derivatives and pharmaceutical applications thereof |
| 10/24/2001 | CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors |
| 10/24/2001 | CN1319094A Imidazolyl derivatives |
| 10/24/2001 | CN1319090A Novel substuted indolimones, their preparation process and use as medicine |
| 10/24/2001 | CN1319017A Insertion stabilizers for implants |
| 10/24/2001 | CN1319014A Use of benzenesulfonyl (thio) ureas for treatment and prophylaxis of dysfunctions of autonomous nervous system and use of benzenesulfonyl(thio) ureas in combination with beta-receptor blockers |
| 10/24/2001 | CN1319012A Method for treating diabetes employing ap2 inhibitor and combination |
| 10/24/2001 | CN1319009A Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |
| 10/24/2001 | CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors |
| 10/24/2001 | CN1319005A Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative |
| 10/24/2001 | CN1319004A New pharmaceutical formulation |
| 10/24/2001 | CN1318541A Sulfonyl pyrrolidone containing compound and its preparation and pharmaceutical application |
| 10/24/2001 | CN1318403A Brain invigorating liquid |
| 10/24/2001 | CN1318401A Medicine for strengthening physique and resisting senility |
| 10/24/2001 | CN1318370A Application of fumaric acid in preparing medicine |
| 10/24/2001 | CN1073565C New 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, processes for their preparation |
| 10/24/2001 | CN1073557C Vitamin-D amide derivatives |
| 10/24/2001 | CN1073429C Scorpion health-care wine |
| 10/24/2001 | CN1073422C Use of progestin for preparing medicine for reducing endometrorrhagia |
| 10/24/2001 | CN1073421C Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta adrenergic antagonist |
| 10/23/2001 | US6307129 Herbicide tolerant plants, plant tissue or plant cells having altered protoporphyrinogen oxidase activity |
| 10/23/2001 | US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 10/23/2001 | US6307080 Water-soluble zinc pyruvates or their hydrates, method for the product ion thereof and their use |
| 10/23/2001 | US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 10/23/2001 | US6307060 Antispasmodic agents |
| 10/23/2001 | US6307056 Inhibit or modulate protein kinases, in particular jnk protein kinases. |
| 10/23/2001 | US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth. |
| 10/23/2001 | US6307044 Process for the preparation of macrocyclic metalloprotease inhibitors |
| 10/23/2001 | US6307027 Bradykinin B1 receptor antibodies |
| 10/23/2001 | US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis |
| 10/23/2001 | US6306993 Method and composition for enhancing transport across biological membranes |
| 10/23/2001 | US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 10/23/2001 | US6306911 Enzyme inhibitors |
| 10/23/2001 | US6306908 Proteins, carbohydrates and lipids |
| 10/23/2001 | US6306897 Calanolides for inhibiting BTK |
| 10/23/2001 | US6306895 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 10/23/2001 | US6306890 Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors |
| 10/23/2001 | US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 10/23/2001 | US6306886 Solid polymorph anticoagulants |
| 10/23/2001 | US6306883 Compounds |
| 10/23/2001 | US6306878 Pharmaceutical compositions containing hydroximic acid derivatives |
| 10/23/2001 | US6306876 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 10/23/2001 | US6306875 Growth-hormone secretagogues |
| 10/23/2001 | US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals. |
| 10/23/2001 | US6306873 Substituted β-thiocarboxylic acids |
| 10/23/2001 | US6306870 N-cinnamoyl derivatives of beta-carboline |
| 10/23/2001 | US6306868 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives |
| 10/23/2001 | US6306867 Treatment of respiratory system disorders, tumor necrosis factor and leukotrienes |
| 10/23/2001 | US6306864 Cerebral deficits subsequent to or resulting from cardiac bypass surgery and grafting, stroke, cerebral ischemia, spinal cord trauma, head trauma |
| 10/23/2001 | US6306852 Indole derivatives useful as endothelin receptor antagonists |
| 10/23/2001 | US6306851 Cyclocarbamate and cyclic amide derivatives |
| 10/23/2001 | US6306849 Selected derivatives of K-252a |
| 10/23/2001 | US6306841 Treatment of female sexual dysfunction |
| 10/23/2001 | US6306840 Cell adhesion inhibitors |
| 10/23/2001 | US6306828 Enantiomerically-enhanced nutritional energy substrates |
| 10/23/2001 | US6306820 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 10/23/2001 | US6306819 Method for regulating size of vascularized normal tissue |
| 10/23/2001 | US6306655 Antisense inhibition of C/EBP alpha expression |
| 10/23/2001 | US6306622 cDNA encoding a BMP type II receptor |
| 10/23/2001 | US6306612 Methods of facilitating vascular growth |
| 10/23/2001 | US6306580 Preparation of human papillomavirus E1 having helicase activity and method therefor |
| 10/23/2001 | US6306444 Flowable drug precursor products ready for pressing for tablets, pellets and sugar-coated tablets and processes for preparing the same |
| 10/23/2001 | US6306432 High and low load formulations of IGF-I in multivesicular liposomes |
| 10/23/2001 | US6306403 Intracranial administration of botulinum toxin into a globus palladius or into ventrolateral thalamus, thereby reducing a dyskinesia of parkinson's disease |
| 10/23/2001 | US6306401 Genetically-engineered sindbis virus with modified E2 Glycoprotein and altered host-range phenotype |
| 10/23/2001 | US6306398 Delipidating plant powder by extraction of powder with a solution containing organic solvent; separating powder from organic solvent; extracting delipidated powder with solvent or phosphate buffered saline; separation to obtain retentate |
| 10/23/2001 | US6306384 Skin battery cosmetic composition |